 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Evaluating the Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
|
|
|
|
Phase IV
|
|
|
|
R01 MH071580
DATR A3-NSS, NCT00352885
|
|
| |
Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
|
|
|
|
Phase IV
|
|
|
|
R01 MH079420
DAHBR 96-BHC, NCT00536172
|
|
| |
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
|
|
|
|
Phase III
|
|
|
|
2003-0925
NCT00418691
|
|
| |
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
|
|
|
|
Phase III
|
|
|
|
2005-0901
NCT00513357
|
|
| |
Palliative Care Study in Patients With Advanced Cancer
|
|
|
|
Phase II
|
|
|
|
AVR118 04-002
NCT00127517
|
|
| |
Yoga in Treating Sleep Disturbance in Cancer Survivors
|
|
|
|
Phase II
|
|
|
|
URCC-U3905
URCC-04-01, URCC 04-01, NCT00397930
|
|
| |
Dexamethasone for Symptom Burden in Advanced Cancer Patients
|
|
|
|
Phase II
|
|
|
|
2005-0816
NCT00489307
|
|
| |
Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer
|
|
|
|
Phase II
|
|
|
|
JHOC-J07110
JHOC-J07110, SKCCC J07110, JHOC-NA_00013024, NCT00641303
|
|
| |
Depression Treatment and Screening in Ovarian Cancer Patients
|
|
|
|
Phase I
|
|
|
|
ID02-258
NCT00515372
|
|
| |
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
|
|
|
|
No phase specified
|
|
|
|
IIR 03-194
01153, 10-0603, CPC-04115-LX, NCT00129467
|
|
